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In Brief
Suijkerbuijk et al. show that growing
tumors in the adult Drosophila posterior
midgut kill surrounding cells and cause
host tissue attrition through a process
called cell competition. Inhibition of cell
competition prevents adenoma growth,
indicating that it is an essential driver of
tumor growth in this tissue.
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Tumor-host interactions play an increasingly recog-
nized role in modulating tumor growth. Thus, under-
standing the nature and impact of this complex
bidirectional communication is key to identifying suc-
cessful anti-cancer strategies. It has been proposed
that tumor cells compete with and kill neighboring
host tissue to clear space that they can expand into;
however, this has not been demonstrated experimen-
tally. Here we use the adult fly intestine to investigate
the existence and characterize the role of competitive
tumor-host interactions. We show that APC/-
driven intestinal adenomas compete with and kill
surrounding cells, causing host tissue attrition.
Importantly, we demonstrate that preventing cell
competition, by expressing apoptosis inhibitors, re-
stores host tissue growth and contains adenoma
expansion, indicating that cell competition is essen-
tial for tumor growth. We further show that JNK
signaling is activated inside the tumor and in nearby
tissue and is required for both tumor growth and
cell competition. Lastly, we find that APC/ cells
display higher Yorkie (YAP) activity than host cells
and that this promotes tumor growth, in part via cell
competition. Crucially, we find that relative, rather
than absolute, Hippo activity determines adenoma
growth. Overall, our data indicate that the intrinsic
over-proliferative capacity of APC/ cells is not un-
controlled and can be constrained by host tissues
if cell competition is inhibited, suggesting novel
possible therapeutic approaches.
INTRODUCTION
It is increasingly recognized that tumors do not simply depend on
their own proliferative capacity for growth, but instead interact
with their environment on multiple levels. For example, the
tumor microenvironment can have a growth-enhancing role by
inducing a wound healing like pro-proliferative milieu [1] or by re-
cruiting tumor enhancing cancer-associated fibroblasts [2, 3].
However, in certain instances, tumor-host interactions have
also been reported to inhibit tumor growth [4]. For example,428 Current Biology 26, 428–438, February 22, 2016 ª2016 The Authembryonic environments have been shown to suppress the
aggressiveness of multiple cancer cells [5, 6]. In addition, in
some contexts, fibroblasts have been shown to limit the growth
and malignancy of neoplastic cells [7]. This suggests that under-
standing how to enhance the tumor suppressive properties of
host tissues may help in the fight against cancer.
Reciprocally, it has also been suggested that precancerous le-
sions and growing tumors could adversely affect the host tissue.
Specifically, it has been proposed that tumor cells could kill
surrounding normal cells and use this strategy to clear space
inwhich they can expand. This suggestion stems from the obser-
vation that in developing tissues, cells with tumor promoting
mutations can induce cell death in nearby wild-type cells [8, 9].
In particular, it has been suggested that cancer cells co-opt a
form of cell interaction normally present in tissues, known as
cell competition [10, 11]. Cell competition was originally discov-
ered in Drosophila when it was found that wild-type cells can kill
cells with mutations that reduce their fitness and growth poten-
tial [12] and has been suggested to act as a quality-control
mechanism to preserve tissue function [13, 14]. It was later found
that in developing tissues, wild-type cells themselves could be
killed via cell competition by mutant cells harboring oncogenic
mutations, so called supercompetitor cells [8, 9]. This led to
the long-standing hypothesis that tumor-host cell competition
might take place and promote tumor formation; however, this
has never been tested directly in adult tissues.
The adult Drosophilamidgut has recently been established as
a model system to study adult stem cell behavior, tissue homeo-
stasis, aging, and regeneration [15–17]. This tissue has a high
cellular turnover and is maintained by newly differentiated cells
produced from intestinal stem cells (ISCs), in a way that is
remarkably similar to the mammalian intestine [17]. Importantly,
mutations that are involved in cancer have also been found
to lead to overgrowth and tumor formation in the fly intestine
[18–20], in some cases by niche appropriation [21]. Furthermore,
we have recently shown that cell competition is active and plays
a role in shaping tissue colonization in this tissue [22]. Overall,
these features provide a unique opportunity to combine the
power of Drosophila genetics and the simplicity of this adult
homeostatic tissue to study the role of cell competition in tumor
formation.
Here we show that Drosophila intestinal tumors compete with
and induce elimination of surrounding cells, causing host tissue
attrition. Importantly, we demonstrate that preventing cell
competition, e.g., by inhibiting cell death, dramatically reduces
tumor growth. Thus, by generating an environment permissiveors
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Figure 1. APC–/– Adenomas Eliminate Surrounding Cells
(A–E) Posteriormidguts harboring control (A andD) orAPC/ (B and E) clones,marked by the absence of GFP (A andB) or by 23GFP (D and E). (A) and (B) show a
maximum intensity projection of multiple z sections in x/y. (D) and (E) show a reconstruction of all z sections in y/z. The graph in (C) displays the distribution of
clone sizes (left, n = 176 clones; right, n = 164 clones).
(F–I0 0) Analysis of cell death in posterior midguts harboring control (F and F0) or APC/ (G, G0, and I–I0 0) clones marked by the absence of hPARP-Venus. Im-
munostaining for cleaved hPARP (red) marks apoptotic cells. The graph in (H) displays the ratio of cleaved-hPARP-positive cells at clone borders (near)
normalized to the rest of the tissue (far). Each dot represents one gut, and the black bar indicates the average ratio (±SD; n = 8 guts per condition). Apoptotic cells
around APC/ adenomas are enterocytes (identified by a polyploid nucleus; I), anti-Prospero-positive enteroendocrine cells (I0) or anti-Delta-positive intestinal
stem cells (I0 0); arrowheads point to apoptotic cells.
Throughout the figures, colored lettering describes fluorescent-protein-positive and white lettering fluorescent-protein negative tissue, and dashed lines indicate
clone borders. Unless stated otherwise, in the graphs each dot represents one clone, red bars indicate median clone sizes, and p values are displayed above
graphs (Mann-Whitney test). Detailed genotypes are listed in the Supplemental Experimental Procedures. Scale bars represent 50 mm.for tumor growth, tumor-induced cell competition acts as a key
driver of tumorigenesis in this tissue, providing a novel angle to
counter tumor expansion.
RESULTS
APC–/–Adenomas InduceApoptosis in SurroundingCells
To investigate whether cell competition takes place at sites of
pre-cancerous lesions, we used mutations in the Adenomatous
polyposis coli (Apc) genes, which cause hyper activation of the
Wnt pathway and induce hyperplasia and benign tumor forma-
tions (hereafter referred to as adenomas) in the adult Drosophila
midgut [19, 20]. We focused on Wnt-induced adenomas
because we previously showed that in developing tissues, cells
with increased Wnt signaling can adopt a supercompetitor
phenotype and cause elimination of normal cells [23]. In addition,Currethe mechanisms driving APC/ hyperplasia in the fly show
important similarities with APC/ intestinal adenoma growth
in mammals (e.g., activation of the oncogene myc in APC/
cells and dependence on Myc activity for adenoma growth
[24]), making our study potentially relevant to the onset of this
pathology.
To generate APC/ intestinal adenomas, we introduced ISCs
mutant for APC1 and APC2 (hereafter referred to as APC/) in
the adult fly posterior midgut by flippase (FLP)-mediated mitotic
recombination (Figure S1A). Clones derived from these cells
were significantly bigger than control wild-type clones of similar
age (Figures 1A–1C) and formedmulti-layered structures bulging
in the lumen of the gut (Figures 1D and 1E), as previously
described [19, 20]. This distorted morphology is visible 10 days
after clone induction (ACI; data not shown), but is more promi-
nent at later stages. To address whether these adenomas inducent Biology 26, 428–438, February 22, 2016 ª2016 The Authors 429
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Figure 2. APC–/– -Induced Cell Competition Causes Attrition of Healthy Tissue
Posterior midguts harboring simultaneously induced GFP-negative WT (A, A0 0, B, and B0 0) and RFP-negative WT (A0 and A0 0) or APC/ (B0 and B0 0) clones. The
graph in (C) displays the distribution of WT clone sizes (left, n = 106 clones; right, n = 227 clones). The graph in (D) shows the percentage of one-cell clones across
a whole population of WT clones in guts containing APC/ clones dissected 10 or 20 days ACI (left, n = 179 clones; right, n = 74 clones; Fisher’s exact test). See
also Figure S2.cell competition, we then looked at the incidence of death in
cells surrounding these clones. Using cleavage of PARP as a
readout for caspase activation, we observed apoptotic cells in
both control guts and guts containing APC/ cells (Figures
1F–1G0). However, although apoptotic cells were randomly
distributed in control epithelia (Figures 1F, 1F0, and 1H, left
graph), we found a 4-fold enrichment in apoptotic cells around
APC/ adenomas (Figures 1G, 1G0, and 1H, right graph).
Increased apoptosis was observed both among the differenti-
ated cell types, i.e., enterocytes (recognized by their large poly-
ploid nuclei; Figure 1I) and enteroendocrine cells (marked by
expression of Prospero; Figure 1I0), and among ISCs (marked
by expression on Delta; Figure 1I0 0). Overall, we conclude that
growing APC/ adenomas induce elimination of nearby cells
by apoptosis.
APC–/–-Induced Cell Competition Causes Attrition of
Healthy Tissue
The increased elimination of cells surrounding APC/ ade-
nomas urged us to further examine the behavior of the host tis-
sue in proximity of adenomas. By labeling the APC mutant and
the wild-type chromosomes with different fluorescent markers,
we could lineage trace simultaneously induced clones of cells
originating either from APC/ (RFP-negative) or from wild-
type (GFP-negative) stem cells (Figure S1B). Interestingly, we
found that wild-type clones were dramatically smaller when
grown in midguts containing APC/ adenomas (Figures 2B
and 2C, right graph) than genetically identical control clones
grown in wild-type epithelia (Figures 2A and 2C, left graph),
with a median clone size of only 25% of their expected size.
In addition, we found that the number of wild-type clones per
gut drops drastically over time (Figure S2A), with the majority
of residual clones made by one cell only at 20 days ACI
(Figure 2D), indicating accelerated clone extinction. Indeed,430 Current Biology 26, 428–438, February 22, 2016 ª2016 The Authwild-type clones in control guts showed a much lower incidence
of one-cell clones (Figure S2B). Altogether, these data indicate
that APC/ adenomas engage in cell competition with sur-
rounding wild-type cells and, by acting as supercompetitors,
cause attrition of the host tissue.
Cell Competition Drives Tumor Growth
Loss of healthy cells in a tumor-bearing environment is detri-
mental to organ function and compromises health [25]. There-
fore, we next asked whether we could protect wild-type tissue
from elimination induced by APC/ adenomas by expressing
inhibitors of apoptosis. Using the GeneSwitch system, which
allows RU486 (mifepristone)-inducible Gal4-driven expression,
we expressed the Drosophila Inhibitor of Apoptosis 1 (DIAP1)
or baculovirus protein p35 directly after clone induction, across
the posterior midgut in both progenitor cells and enterocytes
[22, 26]. Remarkably, we found that inhibition of apoptosis
by DIAP1 (Figures 3A–3C) or p35 (Figures S3A–S3C) expres-
sion was sufficient to fully restore growth of wild-type clones
(Figure 3C; compare also to control clones in Figure 1C, left
graph; p = 0.5694). This indicates that apoptotic induction alone
can account entirely for host tissue attrition during cell
competition.
Strikingly, the growth of APC/ adenomas was drastically
reduced in guts in which the loss of neighboring tissue had
been prevented (Figures 3A0, 3B0, 3D, S3A0, S3B0, and S3D). In
fact, the size of APC/ clones was statistically indistinguishable
from that of wild-type clones within the same guts (compare the
right graphs in Figures 3C and 3D; p = 0.4211). This was not an
indirect effect of inhibition of turnover, since wild-type clone
growth was instead rescued in these same guts (Figures 3A–
3C and S3A–S3C). In addition, DIAP1 or p35 expression did
not affect the behavior of control clones in control guts (Figures
S3E and S3F). Two complimentary experiments confirmed thators
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Figure 3. Cell Competition Fuels Tumor Growth
(A–D) Posterior midguts harboringWT clones (A and B) and APC/ clones, (A0 and B0). Clones are marked by 23GFP (WT) or by the absence of GFP (APC/). In
(B) and (B0 ), cell death was blocked by inducible expression of DIAP1 (+DIAP1; 40 mMRU486). Control guts (A and A0) are of the same genotype as in (B) but were
treated with carrier only (RU486). The graphs in (C) and (D) display the distribution of WT (C; left, n = 59 clones; right, n = 63 clones) or APC/ (D; left, n = 87
clones; right, n = 161 clones) clone sizes.
(E–G) Posterior midguts harboringAPC/ clonesmarked by expression of GFP, with (F; +DIAP1) or without (E; control) additional expression of DIAP1. The graph
in (G) displays the distribution of APC/ clone sizes with (right) or without (left) DIAP1 expression (left, n = 172 clones; right, n = 187 clones).
(H–J) Posterior midguts harboring APC/ clones marked by the absence of RFP. In (I), cell death was blocked in host cells by expression of DIAP1 (+DIAP1;
40 mMRU486). Control guts (H) are of the same genotype as in (I) but were treated with carrier only (RU486). The graph in (J) displays the distribution of APC/
clone sizes with (right) or without (left) DIAP1 expression in host cells (left, n = 160 clones; right, n = 218 clones).
See also Figure S3.
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Figure 4. JNK Signaling Boosts APC–/– Ade-
noma Growth
(A–B0) Posterior midguts stained with anti-phos-
pho (active) JNK (pJNK, red) containing WT (A and
A0) or APC/ clones (B and B0) marked by the
absence of GFP.
(C–F) Posterior midguts harboring WT clones,
marked by 23GFP (C0 and D0 and outlined in C and
D), and APC/ clones, marked by the absence of
GFP (C0 and D0). JNK signaling was blocked by
inducible expression of Puckered (+Puc; 200 mM
RU486; D andD0). Control guts (C andC0) are of the
same genotype as in (D) but were treated with
carrier only (RU486). The graphs in (E) and (F)
display the distribution of clone sizes for WT
clones (E; left, n = 38 clones; right, n = 44 clones)
and APC/ clones (F; left, n = 184 clones; right,
n = 161 clones).
(G–J) Posterior midguts harboring APC/ clones
marked by expression of GFP with (H) or without
(G) additional expression of Puckered within the
clones and stained with anti-phospho H3 to mark
mitotic cells (green) and anti-Delta to mark ISCs
(white). The graphs in (I) and (J) display the per-
centage of APC/ Delta-positive stem cells (I) or
the percentage of mitotic APC/ Delta-positive
stem cells per gut (J). Each dot represents one gut,
and the black bar indicates the average (±SEM;
left, n = 14 guts; right, n = 23 guts; t test).
(K–M) Posterior midguts harboring APC/ clones
marked by the absence of RFP. In (L), JNK
signaling was blocked in host cells by inducible
expression of Puckered (+Puc; 40 mM RU486).
Control guts (K) are of the same genotype as in (L)
but were treated with carrier only (RU486). The
graph in (M) displays the distribution of APC/
clone sizes (left, n = 137 clones; right, n = 227
clones).
See also Figure S4.this effect is due to inhibition of apoptosis specifically in the host
tissue. First, expression of DIAP1 or p35 only in APC/ cells did
not affect their clone size (Figures 3E–3G and S3G–S3H), ruling
out an autonomous effect. Second, conditional inhibition of
apoptosis exclusively in the host tissue (see Figures S1C and
S1D for genetic setup) reduced growth of APC/ adenomas
to a similar extent as inhibition throughout the epithelium (Figures432 Current Biology 26, 428–438, February 22, 2016 ª2016 The Authors3H–3J; compare the right graphs in Fig-
ures 3D and 3J; p = 0.7212). Collectively,
these data demonstrate that tumor-host
cell competition is essential to drive the
growth of APC/ adenomas in the
Drosophila adult midgut.
JNK Signaling Boosts APC–/–
Adenoma Growth Autonomously
and via Cell Competition
We next wondered which pathways are
involved in APC/ adenoma expansion.
The Jun N-terminal kinase (JNK) pathway
plays a fundamental role in modulating
both cell proliferation and cell death inmany tissues, including the fly intestine [27–29], and has been
shown to be required for loser cell elimination in several types
of cell competition [30, 31]. Using a phospho-specific antibody
that recognizes an activated form of JNK, we observed high
JNKactivation specifically in guts that containAPC/ adenomas
(Figures 4B, 4B0, S4A, and S4A0), but not in control wild-type (Fig-
ures 4A and 4A0) or heterozygous APC/+ (Figure S4B) guts.
Hyper-activation of JNK was prominent both inside APC/ ade-
nomas and in surrounding tissue (Figure 4B). This was not an ef-
fect of tissue aging [28] because increased pJNK signal could be
observed as early as 5 days ACI (Figures S4C and S4D). Impor-
tantly, pJNK staining was still present within APC/ clones in
guts in which competition had been blocked by apoptosis inhibi-
tion (Figures S4E and S4F, arrowhead); however, its levels were
reduced in small APC/ clones (Figure S4F), indicating that
clone size is important for JNK activation.
We next tested the relevance of JNK activation to APC/
adenoma growth and cell competition. Interestingly, inhibition
of the pathway throughout the gut epithelium, by GeneSwitch-
induced expression of the JNK inhibitor Puckered (Puc), rescued
wild-type clone size (Figures 4C, 4D, and 4E). Notably, the
growth of APC/ adenomas was severely reduced under these
conditions (Figures 4C0, 4D0, and 4F). Since JNK can have a pro-
proliferative effect, we then asked whether the reduction in
APC/ clone growth was due to a cell-autonomous effect.
Importantly, we found that JNK inhibition in APC/ cells, by
expression of Puc or a dominant-negative version of JNK
(JNKDN) caused a marked reduction in APC/ clone size (Fig-
ures 4G–4H and S4G–S4I). This was accompanied by a reduc-
tion of the proliferation rate and of the proportion of ISCs in
APC/ clones (Figures 4G–4J), both of which have been shown
to be increased in APC/ tumors [19, 20, 24]. This indicates that
JNK signaling is required both for proliferation and for stem cell
fate maintenance in APC/ cells. Note that dependence on
JNK activity for clonal expansion is not a general feature of
ISCs, as JNK signaling inhibition has no effect on the coloniza-
tion of wild-type cells in control guts [22]. Next, to dissect the
role of JNK signaling in cell competition, we inhibited the
pathway in non-tumor cells only. Importantly, inducible expres-
sion of either Puc or JNKDN specifically in the host tissue severely
reduced growth of APC/ adenomas (Figures 4K–4M and S4J–
S4L). Together, these data indicate that JNK signaling has a dual
function: it is required in APC/ cells to promote their growth
and in loser cells for their elimination by cell competition.
It has been shown that, in the fly intestine, expression of the
secreted JAK/STAT cytokine Unpaired-3 (Upd-3) can be acti-
vated by JNK signaling upon stress or injury [22, 27, 29]. Further-
more, the growth ofAPC/ clones has been reported to be JAK/
STAT dependent [24]. However, inhibition of JNK signaling in the
host tissue by expression of JNKDN did not abrogate elevation of
JAK/STAT signaling in APC/ adenomas (Figures S4M and
S4N). Thus, inhibition of JNK signaling in neighboring cells
blocks cell competition in a JAK/STAT-independent manner.
Tumor Growth Is Required for Cell Competition
By monitoring competing clones at 10 and 20 days ACI, we
observed that wild-type clones initially grew (Figures 5A and
5C, left graph) and subsequently shrunk (Figures 5B and 5C,
right graph). This coincided with an increase in APC/ clone
size (Figures 5A0, 5B0, and 5D), suggesting that APC/ clones
need to attain a critical size to compete efficiently. Indeed, block-
ing APC/ clone growth by inhibiting JNK signaling or silencing
of Myc [24] was sufficient to rescue wild-type clone size (Figures
5E–5J). We found that guts containing APC/ clones with an
average size of 30 cells were able to outcompete wild-type
clones (Figure S5A; compare to control size in Figures 2A andCurre2C, left graph), indicating that this is a sufficient size for APC/-
induced competition. Notably, although myc is upregulated in
Drosophila APC/ intestinal adenomas and required for their
overgrowth [24], we found that increasing Myc expression in
host cells did not rescue their outcompetition (Figure S5B) or
inhibit APC/ adenoma growth (Figures 5K–5M). This indicates
that, like in developing epithelia [23], differences inMyc levels are
not required forAPC/-induced cell competition in the intestine.
Relative Differences in Hippo Activity Determine the
Cell Competition Potential of APC–/– Cells
The Hippo pathway plays an important role in growth control and
can inhibitproliferationandpromoteapoptosis via inhibitoryphos-
phorylation of the downstream transcriptional co-activators YAP
and TAZ (Yorkie [Yki] in Drosophila) [32]. Given that Hippo
signaling has been implicated in cell competition in developing tis-
sues [33–35] and that Wnt signaling induces YAP/TAZ activation
in mammals [36, 37], we investigated whether Yki is active in
APC/ adenomas and whether it plays a role in cell competition.
First, we observed that activity of the microRNA and Yki target
gene bantam was high (Bantam-GFP levels were low) in some
APC/ clones (Figures S6A and S6B). Second, diap1-LacZ,
another reporter of Yki activity, was consistently upregulated in
APC/ adenomas (Figures 6A–6A0 0). Interestingly, diap1-LacZ
upregulation was seen predominantly in small cells (Figures 6A–
6A0 0, compare inset 1 to inset 2) and was observed throughout
APC/ clones and not just at clone borders, where cell competi-
tion takes place, suggesting that upregulation of Yki activity is
autonomous to APC/ cells and not a consequence of cell
competition. Consistent with this, inhibiting cell competition by
blocking apoptosis (Figures 6B–6B0 0) or JNK signaling (Figures
S6C and S6D) in the host tissue did not affect the ectopic activa-
tion of diap1-LacZ, despite the severe reduction in clone size.
To test the involvement of Hippo signaling in cell competition,
we aimed to level differences in Yki activity between APC/
clones and their surrounding host tissue. Thus, we removed
one functional copy of the upstream inhibitory kinase Hippo
(hpo42-47/+) or its upstream activator Expanded (exex1/+), with
the aim of marginally decreasing pathway activity across the
gut. Importantly, we found that halving the hpo or ex gene
dosage fully rescued the growth ability of otherwise wild-type
clones (Figures 6C–6F). This was not a consequence of a general
hyper-proliferative response to hpo or ex heterozygosity, as it did
not have any effect on clonal growth in otherwise wild-type guts
(Figures S6E–S6H). Thus, imperceptibly tweaking Hippo activity
is sufficient to abrogate APC/-induced cell competition in this
tissue. Strikingly, the growth of APC/ adenomas was severely
reduced in hpo/+ or ex/+ heterozygous backgrounds (Figures
6C0–6E0 and 6G). This is extremely unexpected, because
removing one copy of a tumor suppressor should instead pro-
mote the proliferative potential of tissues. In contrast, themedian
size of these APC/ clones reverted to that of wild-type clones
in the same tissue (for hpo/+, compare Figures 6D and 6D0 and
the middle graphs in Figures 6F and 6G; p = 0.3744; for ex/+,
compare Figures 6E and 6E0 and the right graphs in Figures 6F
and 6G; p = 0.7621). Importantly, this was not caused by a detri-
mental effect of Yki activity on APC/ adenomas, because
autonomous overexpression of Yki in APC/ cells did not inhibit
their growth (Figures S6I–S6K). Notably, the suppression ofnt Biology 26, 428–438, February 22, 2016 ª2016 The Authors 433
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Figure 5. Tumor Growth Is Required for Cell
Competition
(A–D) Posterior midguts harboring simultaneously
induced GFP-negative WT (A and B) and RFP-
negative APC/ (A0 and B0) clones, dissected
10 days (A) or 20 days (B) ACI. The graphs in (C)
and (D) display the distribution of clone sizes for
WT clones (C; left, n = 179 clones; right, n = 74
clones) or APC/ clones (D; left, n = 231 clones;
right, n = 186 clones).
(E–J)WT clones,marked by the absence of GFP, in
posterior midguts harboring control APC/
clones (E and H) or APC/ clones expressing
Puckered (F) or MycRNAi (I) specifically within the
clone. The graphs in (G) and (J) display the distri-
bution of WT clone sizes (G, left, n = 112 clones; G,
right, n = 62 clones; J, left, n = 164 clones; J, right,
n = 118 clones).
(K–M) Posterior midguts harboring APC/ clones
marked by the absence of RFP. Myc was inducibly
expressed in host cells (L; +Myc; 40 mM RU486).
Control guts (K) are of the same genotype as in (L)
but were treated with carrier only. The graph in (M)
displays the distribution of APC/ clone sizes
(left, n = 119 clones; right, n = 114 clones).
See also Figure S5.APC/ adenoma growth by hpo heterozygosity was not due to
a reduction in JNK (data not shown) or JAK-STAT (Figures S6L
and S6M) signaling. Altogether, these results show that Yki
signaling is activated in APC/ adenomas and plays a role in
APC/-induced cell competition in the intestine and that differ-
ences in Hippo signaling, rather than absolute Hippo activity,
determine the cell competition potential of APC/ adenomas.
DISCUSSION
It has been well over a decade since the first reports of a connec-
tion between cancer-related genes and cell competition [8, 9].434 Current Biology 26, 428–438, February 22, 2016 ª2016 The AuthorsThese and a panoply of subsequent
studies led to the long-standing hypothe-
sis that cell competition contributes to
cancer formation [10, 11]. Here we have
investigated this directly, by exploiting
the recent establishment of the adult
Drosophila intestine as a model system
to study adult tissue homeostasis and tu-
mor formation [15, 18]. Our work shows
that Wnt-induced intestinal adenomas
directly compete with the host tissue.
Importantly, we find that cell competition
is an essential driver of tumor growth.
Indeed, inhibiting cell competition sup-
presses over-proliferation in APC/
cells, effectively blocking tumor formation
(Figure 7). Importantly, this finding dem-
onstrates that the growth of cells with a
mutation considered to be a major driver
of colon cancer is not uncontrolled and
that the cellular environment plays adeterministic role in the behavior of those cells. In this light,
some previously reported observations might, at least in part,
be explained by cell competition. For example, it has been re-
ported that not all micro-metastases have the potential to imme-
diately grow into secondary tumors [38], a phenomenon called
cancer dormancy [38]. Based on our findings, we speculate
that the interaction of such micro-metastasis with their environ-
ment, through cell competition, could play a deterministic role in
their ability to grow or not. Consistent with this hypothesis, it has
been shown that in developing Drosophila tissues cells with mu-
tations in some tumor suppressor genes (e.g., lgl and scribble)
can be eliminated by wild-type cells [39]. It is only through
FG
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Figure 6. Differences in Hippo Activity Determine Cell Competition Potential of APC–/– Cells
(A–B0 0) Posterior midguts with APC/ clones, marked by the absence of RFP 17 days (B) or 20 days (A) ACI. Yki activity was detected by expression of diap1-
LacZ (white, A0 and B0; green, A, A0 0, B, and B0 0). The magnifications in (A) display regions inside (region 1) and outside (region 2) APC/ clones, and arrowheads
point at small APC/ mutant (white arrowheads) or small WT (red arrowheads) cells. Cell death was blocked in (B) by inducible expression of DIAP1 (40 mM
RU486). The magnifications display regions containing APC/ clones, and arrowheads point at small APC/ mutant cells.
(C–G) Guts containing simultaneously inducedGFP-negativeWT (C, D, and E) andRFP-negativeAPC/ (C0, D0, and E0 ) clones in control (C andC0), hpo/+ (D and
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See also Figure S6.acquisition of additional mutations (similarly to ‘‘second hit’’
mutations during tumorigenesis) that those cells overcome
the tumor-suppressive environment of the host and overgrow
[31, 40]. Furthermore, it has recently been found that naturally
occurring cell competition in the thymus protects mice from
developing leukemia [41], lending further support to this notion.
Recently, it has been shown that some mutations involved in
human colon cancer can give a competitive advantage to cells
in the mouse gut. Specifically, oncogenic mutations in K-Ras
[42] or APC [43] endow stem cells with a competitive advantage,
which increases their chances of colonization. On the basis of
clone population dynamics, those studies have proposed thatCurrecell-autonomous differences in cell proliferation or cell survival
rates among wild-type and oncogenically mutated cells account
for their colonization bias. Here we have taken a different
approach, whereby at the same time as scoring adenoma
growth we monitored and manipulated the cell survival probabil-
ity of the host tissue. This has allowed us to uncover cell
interactions among tumor and host cells that cause induction
of cell death in surrounding normal tissue, a feature that
we demonstrate to be essential to enable adenoma growth. In
light of our findings, we suggest that a similar process may
contribute to the colonization bias observed in the mouse intes-
tine [42, 43].nt Biology 26, 428–438, February 22, 2016 ª2016 The Authors 435
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Figure 7. Cell Competition Promotes Tumor Growth in Drosophila
Schematic model depicting how cell competition affects APC/ adenoma growth. Growing APC/ adenomas in the adult Drosophila posterior midgut kill
surrounding cells and cause host tissue attrition. JNK signaling activation in APC/ cells is required for their growth, whereas non-autonomous JNK activation in
the host tissue is required for cell competition. APC/ cells also display higher Yki activity than host cells and this is required for cell competition. Inhibition of cell
competition prevents adenoma growth, indicating that cell competition is an essential driver of tumor growth in this tissue.We further show that growingAPC/ adenomas cause accel-
erated extinction of wild-type competing clones, resulting in
attrition of surrounding tissue. This is remarkable, considering
that it has been shown that APC mutations induce a cytokine-
rich pro-proliferative environment in and around adenomas,
which should instead promote growth [24]. This indicates that
host tissues recede at sites of tumor growth, a process that is
not only disadvantageous because it enhances tumorigenesis,
but is also detrimental to organ performance. Since interfering
with tumor growth inhibits competition and, vice versa, inhibiting
cell competition blocks tumor growth, we propose that both
events occur simultaneously and enhance one another in a feed-
forward loop. Our finding that apoptosis inhibition allows the
host tissue to contain growing adenomas could have important
implications for cancer therapy, as it could provide a strategy
to prevent or delay a lethal aspect of cancer, namely organ failure
[25]. It further suggests that apoptosis inhibitors might constitute
an unexplored arsenal in combination therapies against cancer.
This is a radical suggestion, given that many anti-cancer chemo-
and radiotherapies are, on the contrary, based on the use of
wide-spectrum cell death inducers.
Our work identifies a new role for Yki activity in tumor growth.
In particular, we show that APC/ tumors display increased Yki
activity, consistent with previous findings [36, 37]. Since YAP/
TAZ and Yki are oncogenes, it is paradoxical that halving the
gene dosage of hpo or ex, both of which are Yki inhibitors and
recognized/putative tumor suppressors, should inhibit adenoma
growth. This points at a new unappreciated role of Hippo
signaling, which provides APC/ adenomas with the ability to
compete. Importantly, it further highlights that relative rather
than absolute differences in Hippo activity are important for tu-
mor growth. A hpo or ex heterozygous background (but, interest-
ingly, not yki heterozygosity; Figures S6O and S6P) most likely436 Current Biology 26, 428–438, February 22, 2016 ª2016 The Authlimits the ability of Hippo to inhibit Yki in the host tissue. We
show that although that has no noticeable effect on the behavior
of otherwise wild-type cells under normal conditions, it is suffi-
cient to allow them to withstand the competition from APC/
adenomas. There are several possible mechanistic explanations
for this observation. First, the Hippo pathway is an important
sensor of cell density [44]. This might be relevant because
APC/ tumors disregard the normal morphology of the midgut
epithelium and exhibit higher cell density [20] (Figure 1). There-
fore, one could speculate that leveling Yki activity could give sur-
rounding cells a chance to be less sensitive to cell density and
thereby prevent cell competition. Alternatively, hpo or ex hetero-
zygosity may confer some resistance to cell death induction, as
one of the targets of Yki is the inhibitor of apoptosis DIAP1 [45].
Lastly, there is evidence that the crosstalk between Hippo and
Wnt pathways is bidirectional and that, besides the previously
discussed activation of YAP/TAZ by Wnt, the Hippo pathway
can also restrict Wnt signaling [46]. Reduced Hippo signaling in
surrounding cells could therefore act as a positive feedback to
facilitate Wnt activation in these cells.
Finally, our findings also reveal an important role of the JNK
pathway in APC/-driven adenoma formation. As we show,
JNK activation in APC/ cells and in patches of surrounding tis-
sue is important to drive tumor growth. A similar activation of
JNK has also recently been observed around, but not inside, in-
testinal Notch/ tumors [21]. Interestingly, however, while
Notch/ tumors rely on the niche microenvironment to supply
proliferative JAK/STAT ligands, we find that APC/ tumors,
which also require JAK/STAT activation [24], do not depend on
a supply from the niche. Both JNK and JAK/STAT pathways
are involved in sensing stress, injury, and inflammation and
enabling regeneration and repair in the Drosophila adult gut
[27–29]. This is particularly relevant because there are manyors
reports that inflammation and stress influence tumorigenesis.
For example, colitis, induced by dextran sodium sulfate feeding,
can strongly promote carcinogenesis in APCmin mice [47] and
increase the colonization potential of p53 mutant cells [43].
Furthermore, it has been shown that chronic inflammation
causes a predisposition for colorectal cancer [48], while treat-
ment with anti-inflammatory drugs decreases this probability
[49]. In this regard, we speculate that targeting JNK signaling
could provide a particularly effective therapeutic strategy, as it
could simultaneously inhibit cancer cell growth and protect
host tissue from competition-induced attrition.
Overall, our findings shed light on new potential strategies for
cancer treatment. They suggest that the growth of early lesions
or micro-metastases could be more effectively prevented by
strengthening the surrounding healthy tissue, in addition to
focusing on killing the cancer cells themselves, which is the
main goal of current treatments.
EXPERIMENTAL PROCEDURES
Drosophila Genetics and Stock Maintenance
Detailed information about the Drosophila stocks is given in the Supplemental
Experimental Procedures, along with a list of all the experimental genotypes.
Flies were grown at 25C and fed on standard fly food containing yeast. For
experiments using the GeneSwitch system [50], food was supplemented with
40 or 200 mM RU486 (mifepristone; Sigma-Aldrich, M8046) in 80% EtOH or
with an equal volume of 80%EtOH as control. Single-stem-cell-derived clones
were generated by mitotic recombination using the FLP/FRT (flippase recog-
nition target) system. 1 to 2 days after eclosion, fertilized female flies were
heat shocked in a water bath at 37C for 10 min. Adults were transferred to
fresh vials every 2–3 days and were kept at 25C until dissection at day 17 un-
less stated otherwise.
Immunostaining
Guts were dissected in PBS and fixed for 20 min at room temperature in PBS
containing 3.7% formaldehyde and 0.025%Triton X-100. After several washes
in 0.25% Triton X-100/PBS (washing buffer), guts were blocked for 30 min in a
solution of 0.1% BSA/0.1% Triton X-100/PBS (blocking buffer). They were
then incubated in the appropriate primary antibody diluted in blocking buffer
overnight at 4C. After several washes in washing buffer, guts were incubated
for 2 hr at room temperature with the appropriate secondary antibody,
followed by several washes in washing buffer. Samples were mounted in Vec-
tashield (Vector Laboratories) on a borosilicate glass slide (no. 1.5, VWR Inter-
national). A list of the antibodies used is given in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cub.2015.12.043.
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